WallStreetZenWallStreetZen

NASDAQ: AVBP
Arrivent Biopharma Inc Stock Ownership - Who owns Arrivent Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arrivent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robin LachapelleChief Operating Officer2025-07-112,050$2.28
$4.67kBuy
Robin LachapelleChief Operating Officer2025-07-112,600$2.28
$5.93kBuy
Robin LachapelleChief Operating Officer2025-07-116,503$2.28
$14.83kBuy

1 of 1

AVBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVBP insiders and whales buy or sell their stock.

AVBP Shareholders

What type of owners hold Arrivent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hhlr Advisors Ltd10.86%4,484,672$109.20MInstitution
Hillhouse Investment Management Ltd10.86%4,484,672$109.20MInsider
Infinitum Asset Management LLC9.37%3,868,923$94.21MInstitution
Suvretta Capital Management LLC8.97%3,703,452$90.18MInstitution
Fmr LLC8.25%3,407,549$82.97MInstitution
Orbimed Advisors LLC7.33%3,027,328$73.72MInstitution
Blackrock Inc4.96%2,046,138$49.82MInstitution
Vanguard Group Inc4.92%2,029,531$49.42MInstitution
Octagon Capital Advisors LP4.77%1,971,054$48.00MInstitution
Novo Holdings A4.70%1,942,142$47.29MInstitution

1 of 3

AVBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVBP78.59%21.41%Net Buying
BBOT62.58%37.42%Net Buying
RAPT29.99%70.01%
BCAX70.42%29.58%Net SellingNet Selling
PHAT65.65%34.35%Net SellingNet Selling
View Top Biotech Stocks

Arrivent Biopharma Stock Ownership FAQ

Who owns Arrivent Biopharma?

Arrivent Biopharma (NASDAQ: AVBP) is owned by 93.43% institutional shareholders, 25.45% Arrivent Biopharma insiders, and 0.00% retail investors. Hillhouse Investment Management Ltd is the largest individual Arrivent Biopharma shareholder, owning 4.48M shares representing 10.86% of the company. Hillhouse Investment Management Ltd's Arrivent Biopharma shares are currently valued at $109.07M.

If you're new to stock investing, here's how to buy Arrivent Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.